NCT04951973 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Cho KJ, Kwon O, Kwon JM, Lee Y, Park H, Jeon KH, Kim KH, Park J, Oh BH
Detecting Patient Deterioration Using Artificial Intelligence in a Rapid Response System. Crit Care Med. 2020 Apr;48(4):e285-e289. doi: 10.1097/CCM.0000000000004236.
Kwon JM, Lee Y, Lee Y, Lee S, Park J
An Algorithm Based on Deep Learning for Predicting In-Hospital Cardiac Arrest. J Am Heart Assoc. 2018 Jun 26;7(13). pii: e008678. doi: 10.1161/JAHA.118.008678.

Comparison of Deep Learning Based Early Warning Score and Conventional Screening System in Rapid Response Team Activation in General Ward Patients

Clinical trial NCT04951973 - References